Canagliflozin and Metformin Extended-Release Tablets and Zemplar (Paricalcitol Capsules)
Determining the interaction of Canagliflozin and Metformin Extended-Release Tablets and Zemplar (Paricalcitol Capsules) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canagliflozin / metformin
Brand name: Invokamet, Invokamet XR
Synonyms: Canagliflozin and metformin, Canagliflozin and Metformin
Generic Name: paricalcitol
Brand name: Zemplar
Synonyms: Zemplar
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canagliflozin and Metformin Extended-Release Tablets-Zemplar (Paricalcitol Injection)
- Canagliflozin and Metformin Extended-Release Tablets-Zemplar Injection
- Canagliflozin and Metformin Extended-Release Tablets-Zemplar Intravenous
- Canagliflozin and Metformin Extended-Release Tablets-Zemuron
- Canagliflozin and Metformin Extended-Release Tablets-Zenapax
- Canagliflozin and Metformin Extended-Release Tablets-Zenatane
- Zemplar (Paricalcitol Capsules)-Canagliflozin and Metformin Tablets
- Zemplar (Paricalcitol Capsules)-Canakinumab
- Zemplar (Paricalcitol Capsules)-Canakinumab Subcutaneous
- Zemplar (Paricalcitol Capsules)-Canasa
- Zemplar (Paricalcitol Capsules)-Canasa Pac rectal
- Zemplar (Paricalcitol Capsules)-Canasa rectal